INTELLIA THERAPEUTICS INC's ticker is NTLA and the CUSIP is 45826J105. A total of 263 filers reported holding INTELLIA THERAPEUTICS INC in Q1 2021. The put-call ratio across all filers is 0.75 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $115,000 | -29.0% | 2,228 | 0.0% | 0.01% | -28.6% |
| Q1 2022 | $162,000 | -43.6% | 2,228 | -8.2% | 0.01% | -30.0% |
| Q4 2021 | $287,000 | -36.9% | 2,426 | -28.5% | 0.01% | -28.6% |
| Q3 2021 | $455,000 | -69.8% | 3,394 | -63.6% | 0.01% | -61.1% |
| Q2 2021 | $1,508,000 | +37.5% | 9,313 | -31.9% | 0.04% | +38.5% |
| Q1 2021 | $1,097,000 | -21.5% | 13,670 | -46.8% | 0.03% | -13.3% |
| Q4 2020 | $1,397,000 | +154.5% | 25,681 | -6.9% | 0.03% | +150.0% |
| Q3 2020 | $549,000 | -11.3% | 27,598 | -6.3% | 0.01% | -14.3% |
| Q2 2020 | $619,000 | +57.9% | 29,447 | -8.2% | 0.01% | +55.6% |
| Q1 2020 | $392,000 | -16.8% | 32,076 | 0.0% | 0.01% | -18.2% |
| Q4 2019 | $471,000 | +46.7% | 32,076 | +33.5% | 0.01% | +57.1% |
| Q3 2019 | $321,000 | – | 24,026 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Discovery Value Fund | 572,950 | $19,990,226 | 5.79% |
| HIMENSION CAPITAL (SINGAPORE) PTE. LTD. | 1,145,091 | $39,952,225 | 5.34% |
| MPM BioImpact LLC | 455,238 | $15,883,254 | 4.12% |
| ARK Investment Management | 9,420,782 | $328,691,084 | 2.85% |
| Atlas Venture Associates IX, LLC | 10,000 | $348,900 | 1.74% |
| Ghisallo Capital Management LLC | 250,000 | $8,722,500 | 1.55% |
| Nikko Asset Management Americas, Inc. | 2,976,002 | $103,743,430 | 1.49% |
| Prosight Management, LP | 72,116 | $2,516,127 | 1.37% |
| Rokos Capital Management LLP | 826,063 | $28,391,785 | 1.24% |
| Elmwood Wealth Management, Inc. | 67,899 | $2,368,996 | 1.18% |